Clinical Trial Update: UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating the combination of UCN-01 and fluorouracil in patients with metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• UCN-01 (7-hydroxystaurosporine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED